Drawing for DREAMED ADVISOR

USPTO serial 79267061

DREAMED ADVISOR

Reviewed by CopyMark Law Group

Reg. 6055694Status 700Renewal
Filing date
Status date
Registration date
May 19, 2020
Examiner
SPARROW, MARY
Law office
PUBLICATION AND ISSUE SECTION

What this means

This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with DREAMED ADVISOR?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $1,097*

Plus Government fees of $1,275

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Alex Patel

Alex Patel Patel & Almeida PC22543 Ventura Blvd, Suite 220 #1200Woodland Hills, CA 91364UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
009Ddownloadable software for analysis of medical information in the field of diabetesACTIVE—
010Wearable medical apparatus for the monitoring and compilation of medical information in the field of diabetes; medical apparatus inserted into the human body for the monitoring and compilation of medical information in the field of diabetes; medical apparatus for the compilation of medical information and medical specimens from patients in the field of diabetesACTIVE—
044Medical analysis for the treatment of persons; providing information in the field of medicine; providing information to patients in the field of administering medication; consultancy for medical purposes; medical analysis services relating to the treatment of patients; medical analysis services relating to the treatment of persons; medical care and analysis services relating to patient treatment; medical services in the field of diabetes; providing information via the Internet in the field of diabetes; advisory services relating to healthcare; advisory services relating to healthACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
May 19, 2025REM3COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED—
Apr 14, 2023TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Apr 14, 2023EWAFTEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS—
Apr 14, 2023ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Apr 14, 2023REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Oct 11, 2020FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Sep 17, 2020FICSFINAL DISPOSITION NOTICE SENT TO IB—
Sep 17, 2020FIMPFINAL DISPOSITION PROCESSED—
Aug 19, 2020FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
May 19, 2020R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Mar 3, 2020NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Mar 3, 2020PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Feb 28, 2020GPNXNOTIFICATION PROCESSED BY IB—
Feb 12, 2020OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Feb 12, 2020OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Feb 12, 2020NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jan 24, 2020CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jan 23, 2020XAECEXAMINER'S AMENDMENT ENTERED—
Jan 23, 2020GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Jan 23, 2020GNEAEXAMINERS AMENDMENT E-MAILED—
Jan 23, 2020CNEAEXAMINERS AMENDMENT -WRITTEN—
Jan 22, 2020DOCKASSIGNED TO EXAMINER—
Jan 22, 2020ZZZXPREVIOUS ALLOWANCE COUNT WITHDRAWN—
Jan 14, 2020NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Dec 31, 2019PBCRWITHDRAWN FROM PUB - OG REVIEW QUERY—
Dec 25, 2019NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Dec 11, 2019ALIEASSIGNED TO LIE—
Dec 9, 2019CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Nov 27, 2019TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Nov 26, 2019CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Nov 26, 2019TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Oct 12, 2019RFNTREFUSAL PROCESSED BY IB—
Sep 26, 2019RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Sep 26, 2019RFRRREFUSAL PROCESSED BY MPU—
Sep 20, 2019MAFRAPPLICATION FILING RECEIPT MAILED—
Sep 18, 2019RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Sep 17, 2019CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 16, 2019DOCKASSIGNED TO EXAMINER—
Sep 16, 2019NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Sep 12, 2019REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance